NIPT
Medicover to Buy €44.4M in NIPD Shares, Acquire Majority Stake
In 2018, NIPD struck a partnership deal with Medicover that included an equity investment and R&D cooperation.
Natera Accused of Unfair, Deceptive Billing Practices Related to NIPT Services in New Lawsuit
The plaintiff, a woman who'd used the company's Panorama test during a pregnancy, is asking the court to certify her case a class action.
Sema4 Q3 Revenues Rise 12 Percent
For the quarter ended Sept. 30, the firm reported $43.2 million in revenues, up from $38.6 million in Q3 of 2020 and beating the average Wall Street estimate.
Yourgene Health Q1 Preliminary Revenues Rise 80 Percent
The company also reported a 10 percent increase in fiscal year 2021 revenues, in line with its unaudited results.
Progenity, Natera Jointly Request Dismissal of Patent Litigation
Progenity sought a declaratory judgment from a California court last year that its Innatal NIPT test didn't infringe six patents held by Natera.
Jul 22, 2021
Jul 13, 2021
Natera Inks Distribution Deal With TomaLab for Italy
Jun 14, 2021
BillionToOne Raises $55M in Series B Financing
May 26, 2021
Illumina, Roche Agree to Settle NIPT Patent Lawsuits
Apr 14, 2021
Feb 25, 2021
Natera Revenues Grow 35 Percent in Q4
Nov 9, 2020